Journal list Promote Sponsor
verified SJR 0,227 · Q4 • database Scopus / SJR & Web of Science indexed
Orvosi Hetilap
Hungary · Akademiai Kiado ZRt.
workspace_premium Q4 — Medicine (miscellaneous) lock Subscription

Orvosi Hetilap

Orvosi Hetilap is a journal indexed in SJR in Medicine (miscellaneous) with an H index of 27. It has a price of 900 €. It has an SJR impact factor of 0,227 and it has a best quartile of Q4. It is published in English. It has an SJR impact factor of 0,227.

Orvosi Hetilap focuses its scope in these topics and keywords: kialakult, várható, és, cuff, based, hazai, study, midterm, outcome, ovarian, ...

ISSN: 0030-6002
Publisher: Akademiai Kiado ZRt.
Category: Medicine (miscellaneous)
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,227 Q4
H-index 27
Acceptance rate pie_chart
39%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
900 € Subscription
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,227

H-index

27

Docs (year)

257

Docs 3y

828

Total refs

7133

Cites 3y

534

Citable 3y

813

Cites/Doc 2y

0.73

Ref/Doc

27.75

Immediate OA

900 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

A hosokkfeherjek lehetseges szerepe a petefeszekrak kezeleseben

View more

Vancomycinrezisztens Enterococcusok megjelenese sebeszeti intenziv osztalyon

View more

A Streptococcus pneumoniae (pneumococcus) -infekciok ezer arca

View more

A sarcoma synoviale kezelesi lehetosegei

View more

A normoglykaemia eleresenek korlatai inzulinkezelt 2-es tipusu cukorbetegekben

View more

A nemi dysphoria jogi vonatkozasai es a kezeles folyamata Magyarorszagon

View more

A myeloma multiplex megkozelitese Magyarorszagon 2016-ban

View more

A maj es az immunrendszer

View more

A korai/praefibroticus primer myelofibrosis kivizsgalasa es kezelese egy eset kapcsan

View more

A kinureninrendszer es a stressz

View more

A kieges es a depresszio diagnosztizalasanak elosegitese demografiai es munkahelyi vedo- es kockazati tenyezoik feltarasaval egeszsegugyi szakdolgozok koreben

View more

A jobb pitvar es bal kamra meretenek es funkciojanak osszefuggesei egeszsegesekben. Eredmenyek a haromdimenzios speckle-tracking echokardiografias MAGYAR-Healthy Tanulmanybol

View more
SHOW MORE ARTICLES

A jeghegy csucsa: multiplex faggyumirigy-eredetu bortumor coloncarcinomaban. Muir-Torre-szindroma

View more

75 eve nyilt meg a Magyar Kiralyi Horthy Miklos Tudomanyegyetem Szegeden

View more

A hetevesnel fiatalabb gyermeket nevelo szulok haziorvosokkal valo elegedettsege Magyarorszagon

View more

A hepatitis C-virus-bazispolimorfizmus jelentosege a kezelesben

View more

A hepatitis C patologiaja

View more

A folyoiratcikkek sulya a kulonfele tudomanyteruletek szakirodalmaban: az elmult ket evtized trendjei

View more

A foglalkozasi asztma napjainkban Magyarorszagon

View more

A fogaszati szemely- es aldozatazonositas regi es uj modszerei. Irodalmi attekintes

View more

A fekelybetegseg es a stressz

View more

A dizajner drog metilendioxi-pirovaleron hatasa a fejlodo idegrendszerre kiserletes allatmodellben

View more

A derekfajas: mikor es mit tegyunk?

View more

A cukorbeteg-ellatas mutatoinak alakulasa Magyarorszagon 2001-2014 kozott. Az Orszagos Egeszsegbiztositasi Penztar adatbazis-elemzesenek celja es modszertana

View more

FAQs